Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP296-ATP296, February 1, 2025. Introduction:Nonstenotic carotid plaque is found in some patients with otherwise cryptogenic stroke (CS) but also in normal individuals and patients with stroke of known cause (KS). Methods of vessel imaging were carotid duplex ultrasound, CTA, and MRA.

Plaque 40

Plaque Stroke Strokes Ultrasound 40

DAIC

FEBRUARY 3, 2025

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. 2022 Aug, 80 (9) 934946 Kronenberg F.

Cardiovascular Disease 52

Cardiovascular Disease Aortic valve Biomarkers Innovation 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP205-AWP205, February 1, 2025. The bovine anatomical variation may alter the blood flow dynamics, potentially contributing to the formation and progression of carotid plaques. CTAs were reviewed to assess the carotid stenosis and the anatomy of the aortic arch. N=16, 36.4%; p=0.030).

Anatomy 40

Anatomy Stenosis Aortic Plaque 40

DAIC

MARCH 31, 2025

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose colchicine, 0.5 mg improved several measures of plaque volume changes over a period of 12 months in patients with stable coronary artery disease, Dr. Budoff continued.

Cardiovascular Disease 52

Cardiovascular Disease Plaque Coronary Artery Disease Heart attacks 52

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP288-ATP288, February 1, 2025. After age standardization, the prevalence of cIMT, carotid plaque, and carotid stenosis was 23.24%, 16.75%, and 2.36%, respectively, with moderate to severe carotid stenosis observed in 0.49% of all participants.

Atherosclerosis 40

Atherosclerosis Plaque Stenosis Cardiovascular Disease 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP54-ATMP54, February 1, 2025. Although carotid plaques can be identified on CT angiography (CTA), interpretation is challenging for frontline physicians. Quantification of plaque volume/composition requires much manual effort. 0.76) for calcific plaque and 0.53 (0.49-0.57)

Plaque 40

Plaque Atherosclerosis Stenosis Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP10-ATMP10, February 1, 2025. Recently, cilostazol plus other antiplatelet agents combined therapy (CT) has been reported to reduce recurrent stroke, and eicosapentaenoic acid (EPA) has been reported to reduce the risk of cardiovascular events and plaque progression. 41.40) vs. MT: 9.15% (2.69-25.78),

Stenosis 40

Stenosis Plaque Angioplasty Stroke 40

Dr. S. Venkatesan MD

JANUARY 1, 2025

Welcome to 2025 and best wishes for a great academic journey to all readers. Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24) Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24)

Cardiogenic Shock 59

Cardiogenic Shock Plaque Academic Bicuspid/Mitral 59

Cardiometabolic Health Congress

NOVEMBER 14, 2024

High Lp(a) is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD), aortic stenosis, and all-cause mortality. Elevated Lp(a) is associated with complex, difficult-to-treat atherosclerotic lesions and fast-progressing plaques. Click here to start: Join the Cardiometabolic Health Congress in Boston in 2024.

CME 103

CME Obesity Heart Failure Biomarkers 103